|
GO_0018373
|
GO_0018373 |
|
|
GO_0018372
|
GO_0018372 |
|
|
GO_0018382
|
GO_0018382 |
|
|
GO_0018381
|
GO_0018381 |
|
|
GO_0018380
|
GO_0018380 |
|
|
inulin fructotransferase (DFA-III-forming) activity
|
GO_0033998 |
[Catalysis of the reaction: [(2->1)-beta-D-fructosyl](n) = [(2->1)-beta-D-fructosyl](n-1) + alpha-D-fructofuranose beta-D-fructofuranose 1,2':2,3'-dianhydride. This reaction is the production of alpha-D-fructofuranose beta-D-fructofuranose 1,2':2,3'-dianhydride (DFA III) by successively eliminating the diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal D-fructosyl-D-fructosyl disaccharide.] |
|
neutrophil degranulation
|
GO_0043312 |
[The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.] |
|
inulin fructotransferase (DFA-I-forming) activity
|
GO_0033997 |
[Catalysis of the reaction: [(2->1)-beta-D-fructosyl](n) = [(2->1)-beta-D-fructosyl](n-1) + alpha-D-fructofuranose-beta-D-fructofuranose 1,2':1,2'-dianhydride. This reaction is the production of alpha-D-fructofuranose beta-D-fructofuranose 1,2':2,1'-dianhydride (DFA I) by successively eliminating the diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal D-fructosyl-D-fructosyl disaccharide.] |
|
positive regulation of eosinophil degranulation
|
GO_0043311 |
[Any process that activates or increases the frequency, rate or extent of eosinophil degranulation.] |
|
negative regulation of eosinophil degranulation
|
GO_0043310 |
[Any process that stops, prevents, or reduces the rate of eosinophil degranulation.] |
|
chondroitin B lyase activity
|
GO_0033999 |
[Catalysis of the reaction: dermatan sulfate = n 4-deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate. This reaction is the eliminative cleavage of dermatan sulfate containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucurosonyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated dermatan-sulfate disaccharide (DeltaUA-GalNAC-4S). Chondroitin sulfate B is also known as dermatan sulfate.] |
|
GO_0043349
|
GO_0043349 |
|
|
GO_0043348
|
GO_0043348 |
|
|
GO_0043347
|
GO_0043347 |
|
|
obsolete N-terminal peptidyl-valine deamination
|
GO_0018389 |
[OBSOLETE. The deamination of the N-terminal valine residue of a protein to form isobutyrate.] |
|
obsolete N-terminal peptidyl-valine condensation with pyruvate to form N-pyruvic acid 2-iminyl-L-valine
|
GO_0018388 |
[OBSOLETE. The condensation of pyruvate through the 2-oxo group with the N-terminal valine of proteins to form the derivative N-pyruvic acid 2-iminyl-L-valine.] |
|
obsolete N-terminal peptidyl-amino acid deamination to pyruvic acid
|
GO_0018387 |
[OBSOLETE. The oxidative deamination of N-terminal peptidyl-cysteine, or peptidyl-serine, to form pyruvic acid with an amide bond between its 1-carboxyl group and the N-terminal residue.] |
|
obsolete N-terminal peptidyl-cysteine condensation with pyruvate to form N-pyruvic acid 2-iminyl-L-cysteine
|
GO_0018386 |
[OBSOLETE. The condensation of pyruvate through the 2-oxo group with the N-terminal cysteine of proteins to form the derivative N-pyruvic acid 2-iminyl-L-cysteine.] |
|
GO_0018385
|
GO_0018385 |
|
|
GO_0018384
|
GO_0018384 |
|